Abstract

Objectives: Explore the diagnostic and prognostic value of cyclooxygenase-2 and wnt3a/β-catenin pathway in endometrial cancer.Methods: A prospective cohort study of 93 women underwent hysterectomy at the China-Japan Friendship Hospital (61 patients with primary endometrial carcinoma, and 32 control patients with uterine prolapse or leiomyoma of uterus). Cox2 and β-catenin expression were determined by immunohistochemistry. The serum levels of cox2 and wnt3a were detected via ELISA assays.Results: Patients with endometrial cancer showed overexpression of cox2 and β-catenin, as well as significantly higher serum levels of cox2 and wnt3a. The serum cox2 level, which is highly significant in predicting the risk of disease progression (RR, 9.617, 95% confidence interval, 1.162–79.622, P = 0.036), showed good diagnostic and prognostic potential, with cut-off of 55 U/L, but alongside β-catenin expression in tissues, were related to poor prognosis (RR, 12.426; 95% confidence interval, 1.618–95.450; P = 0.015).Conclusion: Serum levels of cox2 and wnt3a exhibited diagnostic value for endometrial cancer. Cox2 serum levels and β-catenin expression also showed potential value of prognostic prediction. Cox2 serum levels might be a potential marker for early diagnosis and prognosis prediction in endometrial cancer.

Highlights

  • Endometrial cancer (EC), accounting for 20–30%, is one of the three major female genital tract malignancies [1, 2]

  • No significant differences were observed in menopausal status, cesarean history, dysmenorrhea history, diabetes, and arterial hypertension as well (P > 0.05) (Table 1)

  • Our study showed that cox2 serum levels with a cut-off value of 55 U/L were a better predictor of early EC diagnosis, FIGURE 3 | Kaplan-Meier curves for progression-free survival (PFS) and hazard ratios for tumor progression. (A) Comparison of Progression Free Survival (PFS) between cox2 positive group and the negative group. (B) Comparison of PFS between β-catenin positive group and negative group. (C) Comparison of PFS in endometrial cancer patients between those with cox2 serum levels < 55 U/L and those with cox2 serum levels ≥ 55 U/L. (D) PFS in patients with wnt3a serum levels < 25 ng/ml vs patients with wnt3a serum levels ≥ 25 ng/ml. (E) Odds ratio (OR) for diagnosis. (F) Relative Risk (RR) for disease progression

Read more

Summary

Introduction

Endometrial cancer (EC), accounting for 20–30%, is one of the three major female genital tract malignancies [1, 2]. Most of them occurs in women aged 55–65 years, but was recently diagnosed in younger women [2]. EC is divided into two types based on its dependence on estrogen, type I—estrogen-dependent cancer and type II—estrogen independent cancer [2, 3]. The overall survival rate for EC patients is yet to improve, with 288,000 new cases diagnosed and 74,000 deaths registered each year worldwide [4]. Identification of clinically prognostic risk factors is crucial to enhance the survival rate of EC patients. Diagnostic and Prognostic Predicting Effect of Cox

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.